Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–4 of 4 results
Advanced filters: Author: Daniel Rotrosen Clear advanced filters

  • The ITN was founded in 1999 with the goal of achieving “... a robust state of immune tolerance in the absence of ongoing immunotherapy while maintaining a competent immune system”. What are the challenges that have been met along the way and the lessons learnt for future translational research?

    • Jeffrey A. Bluestone
    • Hugh Auchincloss
    • Laurence A. Turka
    Reviews
    Nature Reviews Immunology
    Volume: 10, P: 797-803

  • Regulatory T cell therapies have shown promise for treating autoimmune diseases and aiding transplantation. We summarize a recent NIAID/HESI-sponsored workshop that addressed key issues in non-clinical and clinical development vital to advancing this immune tolerance paradigm.

    • Jeffrey A. Bluestone
    • Bruce K. Burnett
    • Daniel Rotrosen
    News & Views
    Nature Immunology
    Volume: 26, P: 819-824

  • There have been enormous advances in the field of immunology over the past 3 decades, and those advances have had a positive effect on many subspecialties of medicine. Opportunities for even more notable advances remain. However, present and projected budget constraints for the National Institutes of Health have created formidable challenges. This commentary addresses the opportunities and challenges for the field of immunology during a period of restricted budgets.

    • Charles J Hackett
    • Daniel Rotrosen
    • Anthony S Fauci
    Comments & Opinion
    Nature Immunology
    Volume: 8, P: 114-117